Related Experiment Video
Updated: Jun 15, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation
Henrik Watz1, Benjamin Waschki, Trhorsten Meyer
1Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, D-22927 Grosshansdorf, Germany. h.watz@pulmoresearch.de
Insights
Chronic obstructive pulmonary disease (COPD) severity is linked to smaller heart size and dysfunction. Lung hyperinflation, specifically inspiratory-to-total lung capacity ratio, significantly impacts heart size and function, affecting exercise capacity.
Area of Science:
- Cardiology
- Pulmonology
- Medical Imaging
Background:
- The relationship between abnormal lung function and cardiac structure/function in COPD patients is poorly understood.
- Investigating these links is crucial for understanding COPD progression and its systemic effects.
Purpose of the Study:
- To examine the association between lung function parameters and cardiac chamber sizes in COPD patients.
- To determine the impact of lung function on cardiac dysfunction and its relation to exercise capacity (6-min walk distance).
Main Methods:
- Echocardiography was used to assess cardiac chamber sizes and ventricular dysfunction (left ventricular diastolic and right ventricular Tei-index) in 138 COPD patients (GOLD I-IV).
- Lung function was evaluated using spirometry, body plethysmography, and diffusion capacity.
- The 6-min walk distance (6MWD) was measured.
Main Results:
- Cardiac chamber sizes decreased with increasing COPD severity (GOLD stage).
- Static hyperinflation, particularly the inspiratory-to-total lung capacity ratio (IC/TLC), showed stronger correlations with cardiac chamber sizes than airway obstruction or diffusion capacity.
- An impaired left ventricular diastolic filling pattern and right ventricular dysfunction (Tei-index) were observed in patients with lower IC/TLC (< or = 0.25), and this diastolic dysfunction was linked to reduced 6MWD.
Conclusions:
- COPD severity correlates with reduced heart size.
- Lung hyperinflation, especially reduced IC/TLC, appears to be a significant factor in cardiac remodeling and dysfunction in COPD patients.
- Impaired left ventricular diastolic function is independently associated with decreased exercise capacity in COPD.
Background:
Little is known about the role of abnormal lung function in heart size and heart dysfunction in patients with COPD. We studied the relationship of lung function with heart size and heart dysfunction and associated consequences for 6-min walk distance (6MWD) in patients with COPD of different severitites.
Methods:
In 138 patients with COPD (Global Initiative for Obstructive Lung Disease [GOLD] I-IV), we measured the size of all cardiac chambers, left ventricular diastolic dysfunction (relaxation and filling), and global right ventricular dysfunction (Tei-index) by echocardiography. We also measured lung function (spirometry, body plethysmography, and diffusion capacity) and 6MWD.
Results:
The size of all cardiac chambers decreased with increasing GOLD stage. Overall, moderate relationships existed between variables of lung function and cardiac chamber sizes. Static hyperinflation (inspiratory-to-total lung capacity ratio [IC/TLC], functional residual capacity, and residual volume) showed stronger associations with cardiac chamber sizes than airway obstruction or diffusion capacity. IC/TLC correlated best with cardiac chamber sizes and was an independent predictor of cardiac chamber sizes after adjustment for body surface area. Patients with an IC/TLC < or = 0.25 had a significantly impaired left ventricular diastolic filling pattern and a significantly impaired Tei-index compared with patients with an IC/TLC > 0.25. An impaired left ventricular diastolic filling pattern was independently associated with a reduced 6MWD.
Conclusions:
An increasing rate of COPD severity is associated with a decreasing heart size. Hyperinflation could play an important role regarding heart size and heart dysfunction in patients with COPD.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction
